… were collected from end-stage heart failure patients who were … of cardiac transplantation
from end-stage failing hearts with (n … All patients from which non-LVAD end-stage failing LV and …

… All patients had idiopathic dilated cardiomyopathy and experienced end-stage heart
failure despite maximal medical therapy including digitalis, diuretics, and angiotensin-converting …

… toward larger volumes of the end-diastolic pressure-volume … of ventricular remodeling in
end-stage heart failure. However, … seven patients with end-stage idiopathic cardiomyopathy and …

… from patients undergoing heart transplantation because of end-stage heart failure caused
by IDC (n=8) or ICM (n=6). The diagnosis of ischemicheart disease was confirmed by left heart …

… in patients with end-stage heart failure and secondary … to end-stage heart failure (New
York Heart Association … symptomatic benefit from standard heart-failure therapy, continuous …

… afterloads in end-stage heart failure led to a pilot study followed by the large-scale FIRST
testing the efficacy of a continuous intravenous infusion of epoprostenol in heart failure.8, 12 …

… The purpose of this study to determine the occurrence of sudden cardiac death of end-stage
heart failure, two phases of the natural history hypertrophic cardiomyopathy, in closely …

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure
results from altered phosphorylation of contractile proteins | Cardiovascular Research | Oxford …

… heart disease and refractory congestive heart failure. Hearts collected at autopsy from
individuals who died from causes other than cardiovascular disease were used as controls. …

… the population burden of heart failure (CHF), its prognosis and modiŪable risk factors that
promote it. In the general population CHF is chieŊy the end stage of hypertensive, coronary …